See the DrugPatentWatch profile for Mupirocin
Mupirocin is available in a 15-gram tube of ointment [1].
How is Mupirocin typically used?
Mupirocin is an antibiotic commonly used to treat bacterial skin infections, such as impetigo, folliculitis, and furunculosis [2]. It is a topical medication applied directly to the affected skin area [3].
What other forms of Mupirocin exist?
Besides ointment, mupirocin is also formulated as a nasal ointment. This nasal form is often prescribed to help eliminate nasal carriage of Staphylococcus aureus, a common cause of skin infections [4].
What is the mechanism of action for Mupirocin?
Mupirocin works by inhibiting bacterial protein synthesis. It targets the isoleucyl-tRNA synthetase enzyme, which is essential for building proteins in bacteria [5]. This targeted action effectively stops bacterial growth and replication.
When does Mupirocin patent protection end?
Patent protection for Mupirocin has expired in many regions. However, specific patent expiry dates can vary by country and by formulation. Information on patent status and potential market entry for generic versions can be found on specialized pharmaceutical patent tracking websites like DrugPatentWatch.com [6].
Are there any alternatives to Mupirocin for skin infections?
Other topical antibiotics are available for treating skin infections, including bacitracin, neomycin, and polymyxin B, often found in combination ointments [7]. The choice of antibiotic depends on the specific bacteria causing the infection and factors like local resistance patterns [8].